This full session from Advanced Therapies Week 2023 includes presentations dedicated to pioneering a new wave of gene-agnostic gene therapy, and critical technological advancements driving robust development, manufacturing and testing.
After an introduction from Matthew Hewitt, Executive Director Scientific Services, Cell and Gene Therapy at Charles River Laboratories, two presentations followed before a closing panel with a Q&A.
Presentation 1: Pioneering a New Wave of Gene-Agnostic Gene Therapy with Samarendra Mohanty, Co-Founder and President, Nanoscope Therapeutics
Recent advancements in gene therapy
Overview of retinal degenerative disease
Novel, gene-agnostic optogenetics approach to treat retinal degenerative disease
Clinical program overview and next steps
Presentation: Present and Future of Cell and Gene Therapies with Robert Keefe, Chief Development Officer, BlueSphere Bio
Overview of cell therapy progress to date
Critical technological advancements driving robust development, manufacturing and testing
Leveraging a discovery platform to engineer a TCR-T cell therapy product to treat AML
Future direction of the cell therapy industry
This Session was presented at Advanced Therapies Week 2023, in partnership with Charles River.